{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Halozyme Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"HALO"},"Address":{"label":"Address","value":"11388 SORRENTO VALLEY ROAD, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 794-8889"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally."},"CompanyUrl":{"label":"Company Url","value":"https://www.halozyme.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Cortney Caudill","title":"Chief Operations Officer"},{"name":"Helen I. Torley","title":"President, Chief Executive Officer & Director"},{"name":"Michael J. LaBarre","title":"Chief Technical Officer & Senior Vice President"},{"name":"Steve Knowles","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}